← Evidence map

ArticleOncotarget2016

Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D.

Lu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27286447